Teva buying Allergan Generics for $40.5b - Globes
Why Teva Paid $40.5 Billion for Allergan's Generic Business - Knowledge at Wharton
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Dr Reddy's in $350 million deal to buy 8 US drugs from Teva, Allergan - Times of India
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Israel's largest company acquisition: Teva buys Allergan Generics for $40.5 billion, new stage in Israeli business? | EIPA
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva investors fret over $41bn generic drugs deal | Financial Times
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | Fierce Pharma
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva buys Allergan's generic drug unit for $40.5B
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
AbbVie, Teva reach $161.5 million opioid deal in W. Virginia | Crain's Chicago Business
Teva Pharmaceuticals Announces $40.5 Billion Deal For Allergan's Generic Drug Unit
Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Teva nears deal for Allergan's generic drugs unit: source | Reuters.com
Teva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw Pressure - WSJ
Teva's deal with Allergan continues a massive year for pharma M&A — Quartz
